*LRB10410584LAW20660r*Bill SR0105Text LRB104- 10584SR-110 LAWskip 20660to rcontent SENATEhome RESOLUTIONaccessibility WHEREAS,FAQ Seriousfeedback mentalsitemap illnesseslogin likex bipolarQuick disorder,Search: major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise;

andBill WHEREAS,Number WhileBill prolongedKeyword antipsychoticHome useBill mayInformation beCalifornia essentialLaw forPublications theOther treatmentResources ofMy certainSubscriptions conditions,My itFavorites isBill associatedInformation with>> tardiveBill dyskinesiaSearch (TD),>> aText conditionBill markedText byPDF2 uncontrollable,Bill abnormal,PDF and|Add repetitiveTo movementsMy ofFavorites the| face,Version: torso, limbs, or extremities;

and05/30/18 WHEREAS,- PeopleEnrolled at05/15/18 higher- riskIntroduced ofSR-110 TD(2017-2018) includeText those>> olderVotes than>> 55History years,>> peopleBill whoAnalysis are>> Black,Today's women,Law individualsAs withAmended mood>> orCompare substanceVersions use>> disorders,Status intellectual>> disabilities,Comments orTo centralAuthor nervous>> systemAdd injuries,To andMy thoseFavorites with>> highSHARE cumulativeTHIS: antipsychotic exposure;

andSR110:v98#DOCUMENTBill WHEREAS,Start ApproximatelyEnrolled 60% May 30, 2018 ofPassed the IN  estimatedSenate 800,000 May 29, 2018 U.S.CALIFORNIA LEGISLATURE— 2017–2018 REGULAR SESSION Senate Resolution No.

adults110Introduced livingby withSenator TDBeallMay 15, 2018 remainRelative undiagnosed,to andTardive evenDyskinesia mildAwareness TDWeek symptomsLEGISLATIVE canCOUNSEL'S beDIGESTSR stigmatizing110, andBeall. impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention;

andDigest SR0105KeyBill -2-TextWHEREAS, LRB104Many 10584people LAWwith 20660serious, rchronic WHEREAS,mental Theillness, Americansuch Psychiatricas Associationschizophrenia recommendsand routineother TDschizoaffective screeningdisorders, inbipolar theirdisorder, clinicalor guidelinessevere fordepression, antipsychoticrequire treatment,treatment and individuals treated with antipsychoticsmedications orthat experiencingwork abnormalas movementsdopamine shouldreceptor consultblocking theiragents health(DRBAs), careincluding providersantipsychotics; to assess TD risk, receive TD screenings, and determine appropriate treatment together;

andandWHEREAS, WHEREAS,While FDA-approvedongoing treatmentstreatment forwith TDthese medications can providebe optionsvery forhelpful, symptomand managementeven andlifesaving, improvedfor qualitymany ofpeople, lifeit forcan manyalso individualslead livingto withTardive TD;Dyskinesia (TD);

andandWHEREAS, WHEREAS,Many Thepeople Generalwho Assemblyhave cangastrointestinal encouragedisorders, TDincluding screeninggastroparesis, educationnausea, and awarenessvomiting, foralso healthrequire caretreatment providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinicalDRBAs; best practices, including regular TD screenings;

therefore,andWHEREAS, beTreatment itof RESOLVED,gastrointestinal BYdisorders THEwith SENATEDRBAs OFcan THEbe ONEvery HUNDREDhelpful, FOURTHbut GENERALfor ASSEMBLYmany OFpatients THEcan STATElead OFto ILLINOIS,TD; that we declare May 4 through May 10, 2025 as Tardive Dyskinesia Awareness Week (TDAW) in the State of Illinois;

andandWHEREAS, beTD itis furthera RESOLVED,movement Thatdisorder wethat supportis TDAWcharacterized inby recognitionrandom, ofinvoluntary, the importance of early detection and interventionuncontrolled tomovements improveof SR0105different -3-muscles LRB104in 10584 LAW 20660 r outcomes for people living with mental health conditions and prescribed antipsychotics, and we support efforts to raise awareness about the causesface, andtrunk, symptoms of tardive dyskinesia (TD) and theextremities. importance of routine TD screening.

In some cases, people may experience movement of the arms, legs, fingers, and toes.

In some cases, it may affect the tongue, lips, and jaw.

In other cases, symptoms may include swaying movements of the trunk or hips and may impact the muscles associated with walking, speech, eating, and breathing;

and WHEREAS, TD can develop months, years, or decades after a person starts taking DRBAs, and even after they have discontinued use of those medications.

Not everyone who takes a DRBA develops TD, but if it develops it is often permanent;

andWHEREAS, Common risk factors for TD include advanced age and alcoholism or other substance abuse disorders.

Postmenopausal women and people with a mood disorder or a family history of mood disorders are also at higher risk of developing TD;

and WHEREAS, A person is at higher risk for TD after taking DRBAs for three months or longer, but the longer the person is on these medications, the higher the risk of developing TD;

andWHEREAS, Studies suggest that the overall risk of developing TD following prolonged exposure to DRBAs is between 30 and 50 percent;

andWHEREAS, It is estimated that over 60,000 Californians suffer from TD;

andWHEREAS, Years of difficult and challenging research have resulted in scientific breakthroughs in the last year, with two new treatments for TD approved by the United States Food and Drug Administration.

TD is often unrecognized and patients suffering from the illness are commonly misdiagnosed.

Regular screening for TD in patients taking DRBA medications is recommended by the American Psychiatric Association (APA);

and WHEREAS, A patient who is taking a DRBA should see his or her health care providers for regular evaluations to ensure that any signs of TD are recognized.

Healthcare providers should use a rating scale recommended by the APA;

andWHEREAS, Patients suffering from TD often suffer embarrassment due to abnormal and involuntary movements, which leads them to withdraw from society and increasingly isolate themselves as the disease progresses;

andWHEREAS, The caregivers of patients with TD face many challenges and are often responsible for the overall care of the TD patient;

now, therefore, be itResolved by the Senate of the State of California, That the Senate proclaims the week of May 21, 2018, as Tardive Dyskinesia Awareness Week, with the goal of raising awareness of this potentially debilitating disease;

and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.